Healthcare provider profile · identity verified

Michael S Stutesman, M.D.

Internal Medicine · MORGANTON, NC · NPI 1013972587

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	587	166
Levothyroxine Sodium	Levothyroxine Sodium	421	105
Amlodipine Besylate	Amlodipine Besylate	369	114
Lisinopril	Lisinopril	279	89
Omeprazole	Omeprazole	279	88
Valsartan	Valsartan	258	73
Lorazepam	Lorazepam	194	45
Gabapentin	Gabapentin	190	50
Metformin Hcl Er	Metformin Hcl	190	55
Rosuvastatin Calcium	Rosuvastatin Calcium	182	52
Tramadol Hcl	Tramadol Hcl	181	38
Prednisone	Prednisone	162	106
Hydrochlorothiazide	Hydrochlorothiazide	152	47
Metoprolol Succinate	Metoprolol Succinate	138	43
Furosemide	Furosemide	135	47
Losartan Potassium	Losartan Potassium	128	42
Metformin Hcl	Metformin Hcl	126	39
Eliquis	Apixaban	122	25
Pantoprazole Sodium	Pantoprazole Sodium	121	38
Famotidine	Famotidine	114	39
Meloxicam	Meloxicam	113	44
Carvedilol	Carvedilol	112	36
Allopurinol	Allopurinol	107	30
Spironolactone	Spironolactone	104	31
Escitalopram Oxalate	Escitalopram Oxalate	95	27
Pravastatin Sodium	Pravastatin Sodium	91	28
Trazodone Hcl	Trazodone Hcl	88	28
Fluticasone Propionate	Fluticasone Propionate	87	31
Montelukast Sodium	Montelukast Sodium	84	24
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	81	16
Potassium Chloride	Potassium Chloride	79	25
Tamsulosin Hcl	Tamsulosin Hcl	76	22
Ozempic	Semaglutide	75	16
Sertraline Hcl	Sertraline Hcl	74	22
Warfarin Sodium	Warfarin Sodium	69	19
Arexvy	Rsvpref3 Antigen/As01e/Pf	68	68
Glipizide	Glipizide	66	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	21
Albuterol Sulfate Hfa	Albuterol Sulfate	64	27
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	62	17
Duloxetine Hcl	Duloxetine Hcl	58	16
Alprazolam	Alprazolam	57	suppressed
Clonazepam	Clonazepam	57	11
Simvastatin	Simvastatin	56	20
Azithromycin	Azithromycin	55	50
Clopidogrel	Clopidogrel Bisulfate	55	18
Metoprolol Tartrate	Metoprolol Tartrate	55	20
Donepezil Hcl	Donepezil Hcl	51	12
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	47	13
Jardiance	Empagliflozin	45	13
Zolpidem Tartrate	Zolpidem Tartrate	45	suppressed
Alendronate Sodium	Alendronate Sodium	44	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	12
Amoxicillin	Amoxicillin	42	38
Carbidopa-Levodopa	Carbidopa/Levodopa	41	suppressed
Symbicort	Budesonide/Formoterol Fumarate	41	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	38	27
Trulicity	Dulaglutide	37	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	36	suppressed
Paroxetine Hcl	Paroxetine Hcl	36	suppressed
Synthroid	Levothyroxine Sodium	36	11
Xarelto	Rivaroxaban	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	15
Torsemide	Torsemide	35	suppressed
Estradiol	Estradiol	34	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	33	11
Glimepiride	Glimepiride	33	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	30	suppressed
Ondansetron Hcl	Ondansetron Hcl	30	16
Myrbetriq	Mirabegron	28	suppressed
Ezetimibe	Ezetimibe	27	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	11
Tresiba Flextouch U-100	Insulin Degludec	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Finasteride	Finasteride	23	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	22	17
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Ramipril	Ramipril	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	21	18
Benazepril Hcl	Benazepril Hcl	20	suppressed
Ventolin Hfa	Albuterol Sulfate	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Cephalexin	Cephalexin	19	16
Irbesartan	Irbesartan	19	suppressed
Nystatin	Nystatin	19	11
Venlafaxine Hcl	Venlafaxine Hcl	19	suppressed
Fluconazole	Fluconazole	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	15
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Mounjaro	Tirzepatide	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Forteo	Teriparatide	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Linzess	Linaclotide	12	suppressed
Mesalamine Er	Mesalamine	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Baclofen	Baclofen	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Rybelsus	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error